Chlorine in PDB 4nyh: Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core
Protein crystallography data
The structure of Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core, PDB code: 4nyh
was solved by
R.S.Sankhala,
R.K.Lokareddy,
G.Cingolani,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
6.00 /
1.20
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
51.026,
62.723,
178.773,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
13.7 /
17
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core
(pdb code 4nyh). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the
Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core, PDB code: 4nyh:
Jump to Chlorine binding site number:
1;
2;
3;
Chlorine binding site 1 out
of 3 in 4nyh
Go back to
Chlorine Binding Sites List in 4nyh
Chlorine binding site 1 out
of 3 in the Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl302
b:13.2
occ:1.00
|
H
|
A:TYR95
|
2.2
|
13.3
|
1.0
|
H
|
A:THR96
|
2.4
|
13.4
|
1.0
|
HH12
|
A:ARG158
|
2.5
|
13.5
|
1.0
|
HH22
|
A:ARG158
|
2.6
|
13.0
|
1.0
|
HG23
|
A:THR96
|
2.8
|
15.7
|
1.0
|
HA
|
A:THR94
|
2.9
|
12.3
|
1.0
|
HB
|
A:THR94
|
3.0
|
12.2
|
1.0
|
HG1
|
A:THR153
|
3.1
|
15.2
|
1.0
|
N
|
A:TYR95
|
3.2
|
12.7
|
1.0
|
O
|
A:HOH554
|
3.2
|
40.6
|
1.0
|
OG1
|
A:THR96
|
3.2
|
17.6
|
1.0
|
OG1
|
A:THR153
|
3.3
|
15.6
|
1.0
|
NH1
|
A:ARG158
|
3.3
|
13.6
|
1.0
|
HG1
|
A:THR96
|
3.3
|
17.2
|
1.0
|
N
|
A:THR96
|
3.4
|
13.2
|
1.0
|
NH2
|
A:ARG158
|
3.4
|
13.0
|
1.0
|
O
|
A:HOH558
|
3.5
|
33.6
|
1.0
|
CG2
|
A:THR96
|
3.5
|
15.5
|
1.0
|
HE1
|
A:TYR99
|
3.6
|
19.6
|
1.0
|
HG22
|
A:THR94
|
3.6
|
12.8
|
1.0
|
CA
|
A:THR94
|
3.6
|
12.0
|
1.0
|
HG21
|
A:THR96
|
3.6
|
15.8
|
1.0
|
CB
|
A:THR94
|
3.6
|
12.3
|
1.0
|
HD2
|
A:TYR95
|
3.7
|
14.7
|
1.0
|
CD2
|
A:TYR95
|
3.7
|
15.2
|
1.0
|
CZ
|
A:ARG158
|
3.8
|
11.6
|
1.0
|
CB
|
A:THR96
|
3.8
|
14.6
|
1.0
|
CE2
|
A:TYR95
|
3.8
|
14.3
|
1.0
|
C
|
A:THR94
|
3.9
|
12.5
|
1.0
|
HE2
|
A:TYR95
|
3.9
|
14.6
|
1.0
|
HH11
|
A:ARG158
|
4.0
|
13.2
|
1.0
|
HH
|
A:TYR99
|
4.0
|
27.5
|
1.0
|
HH21
|
A:ARG158
|
4.1
|
12.7
|
1.0
|
CG2
|
A:THR94
|
4.1
|
12.4
|
1.0
|
CA
|
A:TYR95
|
4.2
|
13.2
|
1.0
|
CA
|
A:THR96
|
4.2
|
13.0
|
1.0
|
C
|
A:TYR95
|
4.3
|
13.2
|
1.0
|
CG
|
A:TYR95
|
4.3
|
13.8
|
1.0
|
HG22
|
A:THR96
|
4.3
|
15.6
|
1.0
|
O
|
A:HOH551
|
4.4
|
39.2
|
1.0
|
HG21
|
A:THR94
|
4.5
|
12.5
|
1.0
|
CE1
|
A:TYR99
|
4.5
|
21.0
|
1.0
|
CZ
|
A:TYR95
|
4.5
|
15.1
|
1.0
|
CB
|
A:THR153
|
4.7
|
14.3
|
1.0
|
HB
|
A:THR96
|
4.7
|
14.4
|
1.0
|
HA
|
A:THR96
|
4.7
|
13.2
|
1.0
|
OH
|
A:TYR99
|
4.7
|
32.3
|
1.0
|
H
|
A:GLN97
|
4.7
|
13.9
|
1.0
|
H
|
A:THR153
|
4.8
|
11.2
|
1.0
|
CB
|
A:TYR95
|
4.8
|
13.7
|
1.0
|
OG1
|
A:THR94
|
4.9
|
12.5
|
1.0
|
N
|
A:THR94
|
4.9
|
11.3
|
1.0
|
HG23
|
A:THR94
|
4.9
|
12.7
|
1.0
|
CD1
|
A:TYR95
|
4.9
|
13.5
|
1.0
|
HB
|
A:THR153
|
4.9
|
14.8
|
1.0
|
HA
|
A:TYR95
|
5.0
|
13.9
|
1.0
|
|
Chlorine binding site 2 out
of 3 in 4nyh
Go back to
Chlorine Binding Sites List in 4nyh
Chlorine binding site 2 out
of 3 in the Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl302
b:13.9
occ:1.00
|
H
|
B:TYR95
|
2.2
|
13.4
|
1.0
|
H
|
B:THR96
|
2.5
|
14.2
|
1.0
|
HH12
|
B:ARG158
|
2.5
|
13.9
|
1.0
|
HG23
|
B:THR96
|
2.6
|
19.0
|
1.0
|
HH22
|
B:ARG158
|
2.7
|
13.6
|
1.0
|
HA
|
B:THR94
|
2.9
|
12.3
|
1.0
|
HB
|
B:THR94
|
3.0
|
13.7
|
1.0
|
HG1
|
B:THR153
|
3.1
|
17.1
|
1.0
|
N
|
B:TYR95
|
3.2
|
13.3
|
1.0
|
OG1
|
B:THR96
|
3.2
|
25.7
|
1.0
|
HG1
|
B:THR96
|
3.2
|
23.3
|
1.0
|
OG1
|
B:THR153
|
3.3
|
17.0
|
1.0
|
NH1
|
B:ARG158
|
3.3
|
14.0
|
1.0
|
CG2
|
B:THR96
|
3.3
|
18.6
|
1.0
|
N
|
B:THR96
|
3.4
|
14.3
|
1.0
|
O
|
B:HOH624
|
3.4
|
39.2
|
1.0
|
NH2
|
B:ARG158
|
3.4
|
13.6
|
1.0
|
HG21
|
B:THR96
|
3.4
|
18.4
|
1.0
|
O
|
B:HOH669
|
3.5
|
36.9
|
1.0
|
HG22
|
B:THR94
|
3.6
|
14.7
|
1.0
|
CA
|
B:THR94
|
3.6
|
12.1
|
1.0
|
HD2
|
B:TYR95
|
3.6
|
15.1
|
1.0
|
CB
|
B:THR94
|
3.7
|
13.1
|
1.0
|
CD2
|
B:TYR95
|
3.7
|
15.5
|
1.0
|
CB
|
B:THR96
|
3.7
|
18.8
|
1.0
|
HE1
|
B:TYR99
|
3.8
|
22.4
|
1.0
|
CE2
|
B:TYR95
|
3.8
|
15.2
|
1.0
|
CZ
|
B:ARG158
|
3.8
|
13.0
|
1.0
|
HE2
|
B:TYR95
|
3.8
|
16.0
|
1.0
|
C
|
B:THR94
|
3.9
|
12.6
|
1.0
|
HH11
|
B:ARG158
|
4.0
|
13.6
|
1.0
|
CG2
|
B:THR94
|
4.1
|
14.9
|
1.0
|
HH21
|
B:ARG158
|
4.1
|
13.2
|
1.0
|
HG22
|
B:THR96
|
4.2
|
18.9
|
1.0
|
CA
|
B:THR96
|
4.2
|
15.6
|
1.0
|
CA
|
B:TYR95
|
4.2
|
14.0
|
1.0
|
C
|
B:TYR95
|
4.3
|
14.0
|
1.0
|
CG
|
B:TYR95
|
4.3
|
14.4
|
1.0
|
HH
|
B:TYR99
|
4.3
|
24.9
|
1.0
|
HG21
|
B:THR94
|
4.5
|
14.8
|
1.0
|
CZ
|
B:TYR95
|
4.5
|
19.2
|
1.0
|
HB
|
B:THR96
|
4.6
|
18.6
|
1.0
|
CE1
|
B:TYR99
|
4.7
|
22.2
|
1.0
|
HA
|
B:THR96
|
4.7
|
15.9
|
1.0
|
CB
|
B:THR153
|
4.7
|
13.8
|
1.0
|
H
|
B:GLN97
|
4.8
|
18.9
|
1.0
|
H
|
B:THR153
|
4.8
|
13.0
|
1.0
|
CB
|
B:TYR95
|
4.8
|
14.4
|
1.0
|
CD1
|
B:TYR95
|
4.9
|
15.7
|
1.0
|
N
|
B:THR94
|
4.9
|
12.5
|
1.0
|
OG1
|
B:THR94
|
4.9
|
13.9
|
1.0
|
HG23
|
B:THR94
|
4.9
|
14.4
|
1.0
|
CE1
|
B:TYR95
|
4.9
|
18.0
|
1.0
|
HB
|
B:THR153
|
5.0
|
14.5
|
1.0
|
|
Chlorine binding site 3 out
of 3 in 4nyh
Go back to
Chlorine Binding Sites List in 4nyh
Chlorine binding site 3 out
of 3 in the Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Orthorhombic Crystal Form of PIR1 Dual Specificity Phosphatase Core within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl302
b:15.2
occ:1.00
|
H
|
C:TYR95
|
2.2
|
13.9
|
1.0
|
HH12
|
C:ARG158
|
2.5
|
15.3
|
1.0
|
H
|
C:THR96
|
2.6
|
14.5
|
1.0
|
HG23
|
C:THR96
|
2.6
|
17.0
|
1.0
|
HH22
|
C:ARG158
|
2.8
|
15.1
|
1.0
|
HA
|
C:THR94
|
2.9
|
15.4
|
1.0
|
HB
|
C:THR94
|
3.0
|
15.2
|
1.0
|
HG1
|
C:THR153
|
3.1
|
17.9
|
1.0
|
O
|
C:HOH497
|
3.2
|
59.2
|
1.0
|
N
|
C:TYR95
|
3.2
|
13.7
|
1.0
|
NH1
|
C:ARG158
|
3.3
|
14.9
|
1.0
|
OG1
|
C:THR153
|
3.3
|
18.0
|
1.0
|
O
|
C:HOH431
|
3.3
|
27.3
|
1.0
|
OG1
|
C:THR96
|
3.4
|
27.0
|
1.0
|
CG2
|
C:THR96
|
3.4
|
16.2
|
1.0
|
HG1
|
C:THR96
|
3.4
|
23.5
|
1.0
|
N
|
C:THR96
|
3.4
|
14.5
|
1.0
|
HG21
|
C:THR96
|
3.5
|
16.6
|
1.0
|
NH2
|
C:ARG158
|
3.5
|
14.2
|
1.0
|
HD2
|
C:TYR95
|
3.5
|
16.7
|
1.0
|
HG22
|
C:THR94
|
3.6
|
16.8
|
1.0
|
CA
|
C:THR94
|
3.6
|
15.0
|
1.0
|
CD2
|
C:TYR95
|
3.6
|
16.0
|
1.0
|
CB
|
C:THR94
|
3.6
|
15.3
|
1.0
|
CE2
|
C:TYR95
|
3.7
|
17.1
|
1.0
|
HE2
|
C:TYR95
|
3.7
|
17.4
|
1.0
|
CB
|
C:THR96
|
3.8
|
19.0
|
1.0
|
CZ
|
C:ARG158
|
3.9
|
13.5
|
1.0
|
C
|
C:THR94
|
3.9
|
14.7
|
1.0
|
HE1
|
C:TYR99
|
3.9
|
22.7
|
1.0
|
HH11
|
C:ARG158
|
3.9
|
14.4
|
1.0
|
CG2
|
C:THR94
|
4.1
|
16.4
|
1.0
|
HG22
|
C:THR96
|
4.2
|
17.8
|
1.0
|
CA
|
C:TYR95
|
4.2
|
14.8
|
1.0
|
CA
|
C:THR96
|
4.2
|
15.8
|
1.0
|
HH21
|
C:ARG158
|
4.2
|
14.7
|
1.0
|
CG
|
C:TYR95
|
4.3
|
16.2
|
1.0
|
C
|
C:TYR95
|
4.3
|
13.7
|
1.0
|
HH
|
C:TYR99
|
4.3
|
25.9
|
1.0
|
CZ
|
C:TYR95
|
4.4
|
17.7
|
1.0
|
HG21
|
C:THR94
|
4.5
|
16.2
|
1.0
|
HA
|
C:THR96
|
4.7
|
16.2
|
1.0
|
HB
|
C:THR96
|
4.7
|
18.8
|
1.0
|
CB
|
C:THR153
|
4.7
|
15.2
|
1.0
|
CB
|
C:TYR95
|
4.8
|
16.7
|
1.0
|
CE1
|
C:TYR99
|
4.8
|
23.3
|
1.0
|
CD1
|
C:TYR95
|
4.8
|
15.9
|
1.0
|
H
|
C:THR153
|
4.9
|
14.6
|
1.0
|
N
|
C:THR94
|
4.9
|
15.3
|
1.0
|
OG1
|
C:THR94
|
4.9
|
16.4
|
1.0
|
HG23
|
C:THR94
|
4.9
|
16.6
|
1.0
|
CE1
|
C:TYR95
|
4.9
|
17.7
|
1.0
|
H
|
C:GLN97
|
4.9
|
17.3
|
1.0
|
|
Reference:
R.S.Sankhala,
R.K.Lokareddy,
G.Cingolani.
Structure of Human PIR1, An Atypical Dual-Specificity Phosphatase. Biochemistry V. 53 862 2014.
ISSN: ISSN 0006-2960
PubMed: 24447265
DOI: 10.1021/BI401240X
Page generated: Thu Jul 25 23:07:59 2024
|